Non-Small Cell Lung Cancer (NSCLC)
Showing 26 - 50 of >10,000
Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)
Not yet recruiting
- Advanced Non Small Cell Lung Cancer
- (no location specified)
Oct 24, 2023
Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))
Recruiting
- Non Small Cell Lung Cancer
- TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
-
Leiden, Zuid-Holland, Netherlands
- +1 more
Jun 1, 2023
NSCLC (Non-small-cell Lung Cancer) Trial in Changchun (Sintilimab, IBI310)
Recruiting
- NSCLC (Non-small-cell Lung Cancer)
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Sep 21, 2022
Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Lung Cancer Stage III
- Nivolumab and Chemotherapy
- +3 more
- (no location specified)
Aug 15, 2023
Results of Specific Gene Testing and Efficacy of Targeted
Completed
- Non Small Cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Mar 27, 2023
NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Anlotinib Hydrochloride
- +2 more
- (no location specified)
Aug 2, 2022
NSCLC Trial in Guangzhou (BL-M07D1)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 1, 2023
NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)
Recruiting
- Non-small Cell Lung Cancer
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Jun 27, 2023
NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Amivantamab
- +6 more
- (no location specified)
Nov 7, 2023
Non Small Cell Lung Cancer Trial in Beijing (DZD9008)
Recruiting
- Non Small Cell Lung Cancer
-
Beijing, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, Peking Uni
Sep 24, 2022
Efficacy and Safety of Anlotinib for Advanced Non-small Cell
Completed
- NSCLC
-
Wuhan, Hubei, ChinaHubei province
Oct 19, 2022
NSCLC Trial in Iowa City ([18F]F-ARAG PET)
Not yet recruiting
- Non-small Cell Lung Cancer
- [18F]F-ARAG PET
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 10, 2023
NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)
Recruiting
- NSCLC
- SBRT+LDRT
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Apr 2, 2023
NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)
Not yet recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- (no location specified)
Mar 24, 2023
NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- SKB264
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University, Cancer Center
Apr 14, 2023
NSCLC (NSCLC) Trial in Switzerland (Lifestyle)
Not yet recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- Lifestyle
-
Barmelweid, Switzerland
- +3 more
Apr 25, 2023
Lung Cancer, Non Small Cell Lung Cancer, Adenocarcinoma of Lung Trial run by the National Cancer Institute (NCI) (LMB-100,
Active, not recruiting
- Lung Cancer
- +2 more
- LMB-100
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 4, 2022
NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 3, 2023
d To Treat People With Non-Small Cell Lung Cancer
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
-
Tokyo, JapanTakeda Selected Site
Oct 13, 2022